Listing 1 - 10 of 40 | << page >> |
Sort by
|
Choose an application
For thousands of years, pharmacological knowledge coming from natural remedies, has been handed down from generation to generation, without any awareness of the ways in which preparations are made to face diseases. The advent of pharmaceutical chemistry and of the modern drug industry turned that lack of awareness into a scientific knowledge that changed the destiny of the human race. The twenty-eight chapters of this book, are taken from the lectures held by Professor Ettore Novellino every year in his course “Pharmaceutical Chemistry and Toxicology 2”. The first chapters address the basic notions of drugs, homeostasis, pharmacopoeia, and receptor; then, the different pharmaceutical classes are introduced by analyzing their pharmacological and chemical aspects. In particular, the structural study of the interaction between drugs and receptors or biological enzymes gives the fundamentals to connect the chemical and stereochemical properties of a compound family, with the biological activity, a correlation better known as Quantitative Structure-Activity Relationship (QSAR). Several examples of the synthesis of some of the most historically renown drugs, provided at the end of each chapter, integrate the book.
Choose an application
For thousands of years, pharmacological knowledge coming from natural remedies, has been handed down from generation to generation, without any awareness of the ways in which preparations are made to face diseases. The advent of pharmaceutical chemistry and of the modern drug industry turned that lack of awareness into a scientific knowledge that changed the destiny of the human race. The twenty-eight chapters of this book, are taken from the lectures held by Professor Ettore Novellino every year in his course “Pharmaceutical Chemistry and Toxicology 2”. The first chapters address the basic notions of drugs, homeostasis, pharmacopoeia, and receptor; then, the different pharmaceutical classes are introduced by analyzing their pharmacological and chemical aspects. In particular, the structural study of the interaction between drugs and receptors or biological enzymes gives the fundamentals to connect the chemical and stereochemical properties of a compound family, with the biological activity, a correlation better known as Quantitative Structure-Activity Relationship (QSAR). Several examples of the synthesis of some of the most historically renown drugs, provided at the end of each chapter, integrate the book.
Choose an application
QSAR in Safety Evaluation and Risk Assessment provides comprehensive coverage on QSAR methods, tools, data sources, and models focusing on applications in products safety evaluation and chemicals risk assessment. Organized into five parts, the book covers almost all aspects of QSAR modeling and application. Topics in the book include methods of QSAR, from both scientific and regulatory viewpoints; data sources available for facilitating QSAR models development; software tools for QSAR development; and QSAR models developed for assisting safety evaluation and risk assessment. Chapter contributors are authored by a lineup of active scientists in this field. The chapters not only provide professional level technical summarizations but also cover introductory descriptions for all aspects of QSAR for safety evaluation and risk assessment.
Drugs --- QSAR (Biochemistry) --- Quantitative structure-activity relationships (Biochemistry) --- Structure-activity relationships (Biochemistry) --- Structure-activity relationship (Pharmacology) --- Pharmaceutical chemistry --- Pharmacology --- Structure-activity relationships. --- Quantitative Structure-Activity Relationship --- Consumer Product Safety --- Environmental Pollutants --- Toxicity Tests
Choose an application
Biopharmaceutics. --- Pharmaceutical chemistry. --- Structure-activity relationships (Biochemistry) --- Pharmaceutical chemistry --- Biopharmaceutics --- Chemistry, Pharmaceutical --- Structure-Activity Relationship --- Chimie pharmaceutique --- Biopharmacie. --- Chimie pharmaceutique. --- Relations structure-activité (Biochimie)
Choose an application
Drugs --- Xenobiotics --- QSAR (Biochemistry) --- Biology --- Chemistry --- Models, Molecular --- Structure-Activity Relationship --- Médicaments --- Xénobiotiques --- Relations structure-activité quantitatives (Biochimie) --- Structure-activity relationships --- Relations structure-activité --- Relationship, Structure-Activity --- Relationships, Structure-Activity --- Structure Activity Relationship --- Structure-Activity Relationships --- Molecular Models --- Model, Molecular --- Molecular Model --- Quantitative structure-activity relationships (Biochemistry) --- Foreign chemical compounds --- Foreign compounds --- Xenobiotic compounds --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Molecular Conformation --- Molecular Structure --- Structure-activity relationships (Biochemistry) --- Biochemistry --- Chemicals --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Biology. --- Chemistry. --- Computer Graphics. --- Models, Molecular. --- Pharmacoloogy. --- Structure-Activity Relationship. --- Pharmacology. --- Computer Graphic --- Graphic, Computer --- Graphics, Computer --- Pharmacologies --- Pharmaceutical Preparations --- pharmacology
Choose an application
Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural chemistry, and chemical and physical properties along with various approaches for their synthesis.
Drug development. --- Pyrimidines. --- Heterocyclic compounds --- Development of drugs --- Drugs --- New drug development --- Pharmacology --- Pharmacy --- Development --- Heterocyclic chemistry. --- Heterocyclic compounds. --- Pyrimidines --- Heterocyclic Compounds, Fused-Ring --- Drug Discovery --- Organic Chemistry Phenomena --- Chemistry, Pharmaceutical --- Structure-Activity Relationship --- Research. --- chemistry --- chemical synthesis --- methods
Choose an application
Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development aims at showcasing different structure-based, ligand-based, and machine learning tools currently used in drug design. It also highlights special topics of computational drug design together with the available tools and databases. The integrated presentation of chemometrics, cheminformatics, and machine learning methods under is one of the strengths of the book.The first part of the content is devoted to establishing the foundations of the area. Here recent trends in computational modeling of drugs are presented. Other topics present in this part include QSAR in medicinal chemistry, structure-based methods, chemoinformatics and chemometric approaches, and machine learning methods in drug design. The second part focuses on methods and case studies including molecular descriptors, molecular similarity, structure-based based screening, homology modeling in protein structure predictions, molecular docking, stability of drug receptor interactions, deep learning and support vector machine in drug design. The third part of the book is dedicated to special topics, including dedicated chapters on topics ranging from de design of green pharmaceuticals to computational toxicology. The final part is dedicated to present the available tools and databases, including QSAR databases, free tools and databases in ligand and structure-based drug design, and machine learning resources for drug design. The final chapters discuss different web servers used for identification of various drug candidates.
Machine learning. --- Learning, Machine --- Artificial intelligence --- Machine theory --- Drugs --- Drug development. --- QSAR (Biochemistry) --- Cheminformatics. --- Machine learning --- Quantitative Structure-Activity Relationship --- Cheminformatics --- Machine Learning --- Drug Design --- Structure-activity relationships. --- Therapeutic use.
Choose an application
Outside back cover : "Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, only a fraction have sufficient ADME (absorption, distribution, metabolism, elimination) properties, and acceptable toxicology properties, to become a drug product that will successfully complete human Phase I clinical trials. Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, Second Edition, provides scientists and students the background and tools to understand, discover, and develop optimal clinical candidates. This valuable resource explores physiochemical properties, including solubility and permeability, before exploring how compounds are absorbed, distributed, and metabolized safely and stably. Review chapters provide context and underscore the importance of key concepts such as pharmacokinetics, toxicity, the blood-brain barrier, diagnosing drug limitations, prodrugs, and formulation. Building on those foundations, this thoroughly updated revision covers a wide variety of current methods for the screening (high throughput), diagnosis (medium throughput) and in-depth (low throughput) analysis of drug properties for process and product improvement. From conducting key assays for interpretation and structural analysis, the reader learns to implement modification methods and improve each ADME property. Through valuable case studies, structure-property relationship descriptions, and structure modification strategies, Drug-Like Properties, Second Edition, offers tools and methods for ADME/Tox scientists through all aspects of drug research, discovery, design, development, and optimization.Provides a comprehensive and valuable working handbook for scientists and students in medicinal chemistry. Includes expanded coverage of pharmacokinetics fundamentals and effects. Contains updates throughout, including the authors’ recent work in the importance of solubility in drug development; new and currently used property methods, with a reduction of seldom-used methods; and exploration of computational modeling methods"
Pharmaceutical chemistry. --- Drugs --- Drug development. --- Structure-activity relationships. --- Design. --- Drug Design --- Drug Evaluation, Preclinical --- Drug-Related Side Effects and Adverse Reactions --- Pharmaceutical Preparations --- Pharmacokinetics --- Structure-Activity Relationship --- Drug design --- Pharmaceutical design --- Drug development --- Development of drugs --- New drug development --- Pharmacology --- Pharmacy --- Structure-activity relationship (Pharmacology) --- Pharmaceutical chemistry --- Structure-activity relationships (Biochemistry) --- Chemistry, Medical and pharmaceutical --- Chemistry, Pharmaceutical --- Drug chemistry --- Medical chemistry --- Medicinal chemistry --- Pharmacochemistry --- Chemistry --- Development
Choose an application
Chemistry --- QSAR (Biochemistry) --- Structure-activity relationships (Biochemistry) --- Drugs --- Quantitative Structure-Activity Relationship. --- Combinatorial Chemistry Techniques. --- Biology. --- Pharmacology. --- Relations structure-activité quantitatives (Biochimie) --- Relations structure-activité (Biochimie) --- Médicaments --- Structure-activity relationships --- Relations structure-activité --- Structure-activity relationships. --- Health Sciences --- Life Sciences --- Biochemistry --- Pharmacy and Pharmacology --- Biochemorphology --- Biomolecules --- Chemical structure-biological activity relationships --- Relationships, Structure-activity (Biochemistry) --- Quantitative structure-activity relationships (Biochemistry) --- Structure-activity relationship (Pharmacology) --- Pharmacologies --- Pharmaceutical Preparations --- Chemistry Technic, Combinatorial --- Chemistry Technics, Combinatorial --- Chemistry Technique, Combinatorial --- Combinatorial Chemistry Technic --- Combinatorial Chemistry Technics --- Combinatorial Chemistry Technique --- Technic, Combinatorial Chemistry --- Technics, Combinatorial Chemistry --- Technique, Combinatorial Chemistry --- Chemistry Techniques, Combinatorial --- Techniques, Combinatorial Chemistry --- 3D-QSAR --- QSAR --- QSPR Modeling --- Quantitative Structure Property Relationship --- Structure Activity Relationship, Quantitative --- 3D QSAR --- 3D-QSARs --- Modeling, QSPR --- Quantitative Structure Activity Relationship --- Quantitative Structure-Activity Relationships --- Relationship, Quantitative Structure-Activity --- Relationships, Quantitative Structure-Activity --- Structure-Activity Relationship, Quantitative --- Structure-Activity Relationships, Quantitative --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- pharmacology --- Physical biochemistry --- Pharmaceutical chemistry --- Pharmacology --- Gene Library --- Peptide Library --- Oligonucleotide Array Sequence Analysis --- High-Throughput Screening Assays --- Click Chemistry --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacy --- Pharmacy, Therapeutics, & Pharmacology
Choose an application
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less desirable as a drug product.
Pharmacology. Therapy --- Drug Design. --- Drug Evaluation, Preclinical. --- Drug Toxicity. --- Pharmaceutical Preparations --- Pharmacokinetics. --- Structure-Activity Relationship. --- Pharmaceutical chemistry. --- Drugs --- Drug development. --- Chimie pharmaceutique --- Médicaments --- metabolism. --- Structure-activity relationships. --- Design. --- Relations structure-activité --- Développement --- Conception --- Pharmaceutical chemistry --- Drug development --- Structure-activity relationships --- Design --- Drug design --- Pharmaceutical design --- Development of drugs --- New drug development --- Pharmacology --- Pharmacy --- Structure-activity relationship (Pharmacology) --- Structure-activity relationships (Biochemistry) --- Chemistry, Medical and pharmaceutical --- Chemistry, Pharmaceutical --- Drug chemistry --- Medical chemistry --- Medicinal chemistry --- Pharmacochemistry --- Chemistry --- Development --- Drug-Related Side Effects and Adverse Reactions. --- Drugs - Structure-activity relationships --- Drugs - Design
Listing 1 - 10 of 40 | << page >> |
Sort by
|